What dosing schedule and titration plan are you recommending, and what should I do if I experience side effects
Diabetes remission in the alliance of randomized trials of medicine versus metabolic surgery in type 2 diabetes (ARMMS-T2D)
"We originally began building this tracker for Ro patients but knew that our scaled supply data and tech expertise positioned us to help all patients (whether Ro patient or not) navigate the shortage and have a greater chance of finding the GLP-1 medications they need." The GLP-1 Supply Tracker leverages Ro's proprietary, nationwide supply data as well as user-generated reports along with the latest information from the FDA's Drug Shortage List
Purity is calculated by integrating the area under the curve (AUC) of the main peak and expressing it as a percentage of the total area of all peaks
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
Nutrients and supplements that matter for both conditions Hashimoto's patients on GLP-1 medications face a double challenge: the autoimmune condition depletes certain nutrients, and the GLP-1 medication's appetite suppression and altered gastric emptying can reduce nutrient intake and absorption further
